Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Pediatrics/Neonatology | Psychiatry/Psychology | Family Medicine
Search Medical Condition
Depression (Pediatric) Clinical Trials
A listing of Depression (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (24) clinical trials
Stanford MOMENTUM Study- We are currently recruiting children and adolescents to participate in a brain-imaging study to understand how appetite and mood are related.
We are currently recruiting children and adolescents between the ages of 9-17 to participate in a brain-imaging study to understand how appetite and mood are related. Through this study, we hope to learn more about the neurological systems critical for the response and regulation of reward that contribute to both ...
Adolescents with Depression and/or Anxiety and a Parent or Sibling with Bipolar Disorder
The purpose of this research study is to investigate brain changes in adolescents who are currently experiencing depressive and/or anxiety symptoms and have a family history of bipolar disorder. Participants will be randomized to escitalopram and psychotherapy or placebo and psychotherapy for 16-week treatment.
Pediatric Patients With Major Depressive Disorder
A Multicenter, Double-blind, Placebo- and Active-Controlled, Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder
A Phase 4 clinical trial for adolescents (6-16) with Anxiety, Depression, or OCD.
A clinical study designed to collect information on the safety and efficacy of an anti-depressant to treat depression, OCD, or anxiety with or without CBT therapy.
Does your child have major depressive disorder?
If your child is 12 to 17 years old and has been diagnosed with major depressive disorder (MDD) or has been having feelings of depression for at least the past 6 weeks, he or she may be eligible to join the STEADi (Study To Evaluate an Adolescent Depression Investigational drug) ...
Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.
Investigation of the efficacy and safety of a new potential treatment of Major depressive disorder (MDD) in pediatric patients (age 7 to 17 years)
The Kites research study If your child is affected by depression and still experiencing its symptoms – you may be interested in the Kites study. Kites is an international clinical research study that is looking at the safety and effectiveness of an investigational medicinal product for major depression in children ...
Depression Study for ages 7-17
Clinical trials of Texas, Inc. is conducing a research study for children ages 7-17 who are exhibiting symptoms of depression. Symptoms include sadness, loss of interest in things, feeling like a failure, discouragement and even some suicidal thoughts. Qualified participants receive study-related medical care from a board certified psychiatrist.
Study of Intranasal Esketamine as Add-On Treatment for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide
The purpose of this study is to assess the efficacy of a single (first) dose of 3 fixed doses of intranasal esketamine {28 milligram (mg), 56 mg, and 84 mg} compared with psychoactive placebo (oral midazolam) in rapidly reducing the symptoms of major depressive disorder (MDD) including suicidal ideation in ...
Study of Vortioxetine in Pediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
Investigation of the efficacy and safety of a new potential treatment of Major depressive disorder (MDD) in paediatric patients (age 7 to 11 years)
